It has been observed that enhanced interaction between EPHA3 and its ligand ephrin-A5/Fc in rhabdomyosarcoma modulates Rho GTPases, leading to a decrease in cell–fibronectin adhesion and migration toward stromal cell-derived factor 1 (SDF-1) [28]. Here, EPHA3 is linked to rhabdomyosarcoma.